Newsfeeds Archive - Spark Newswire

5 minute read

‘Oregon’s First-In-Nation Psilocybin Industry Is Struggling To Find Paying Customers A Year After Launching’ – Marijuana Moment

June 12, 2:07 PM

https://www.marijuanamoment.net/oregons-first-in-nation-psilocybin-industry-is-struggling-to-find-paying-customers-a-year-after-launching/"Unfortunately we've seen one service center close down. I imagine there will be

CMPS

1 minute read

Movers

12 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights

June 7, 8:08 AM

Gainers Venus Concept (NASDAQ:VERO) shares increased by 135.2% to $1.38 during Friday’s pre-market session. The market value of…

ANL

1 minute read

Seelos Therapeutics Approves 1-For-8 Reverse Stock Split, To Begin Trading On A Reverse Stock Split-Adjusted Basis At The Opening Of The Market On Thursday, May 16, 2024

By Benzinga Newsdesk

May 14, 11:51 AM

Seelos Therapeutics, Inc. (NASDAQ:SEEL) ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today

SEEL

2 minute read

“FDA Expert Committee Will Review MDMA-Assisted Therapy For PTSD Next Month” – Marijuana Moment

By Benzinga Newsdesk

May 7, 11:54 AM

https://www.marijuanamoment.net/fda-expert-committee-will-review-mdma-assisted-therapy-for-ptsd-next-month/The Food and Drug Administration (FDA) is taking the next step in its historic review of MDMA-assisted therapy

CMPS

2 minute read

Movers

12 Health Care Stocks Moving In Monday’s After-Market Session

By Benzinga Insights

April 29, 4:31 PM

Gainers GeneDx Hldgs (NASDAQ:WGS) shares increased by 21.8% to $13.4 during Monday’s after-market session. The market value of…

COSM

2 minute read

Seelos Therapeutics Announces Strategic Focus On Mental Health Initiatives And Provides An Update On Current Discussions Of Potential Partnerships And Collaboration; Richard Pascoe Appointed Chairman Of The Board

By Benzinga Newsdesk

April 29, 8:11 AM

-Richard Pascoe appointed Chairman of the Board of Directors to spearhead the ongoing business development discussionsNEW YORK, April 29, 2024 /PRNewswire/ -- Seelos Therapeutics, Inc. (NASDAQ:SEEL) ("Seelos"), a

SEEL

4 minute read

Psyched: Psychedelics & Sex, MDMA And Federal Approval, Canadians For End-Of-Life Care And More

By Lara Goldstein

February 15, 9:36 AM

Can Psychedelics Increase Sexual Interest And Satisfaction? Study Says Yes And Effects Can Last Months A new study…

ATAI

3 minute read

‘FDA Grants Priority Review Of MDMA-Assisted Therapy For PTSD, Psychedelics Drug Development Company Says’ – Marijuana Moment

By Benzinga Newsdesk

February 12, 12:38 PM

https://www.marijuanamoment.net/fda-grants-priority-review-of-mdma-assisted-therapy-for-ptsd-psychedelics-drug-development-company-says/ The Food and Drug Administration (FDA) has agreed to review

CMPS

4 minute read

Psyched: Suggestibility And Psychedelics’ Effects, EU’s $7M Research Fund, Australia’s Treatment Delivery, BZ Podcast And More

By Lara Goldstein

January 27, 11:00 AM

New study finds suggestibility plays a role in antidepressant effects of psilocybin therapy. EU invests 6.5M euros in psychedelics for pulmonary disorder, MS, ALS, and Parkinson's. Australian psychiatrists provide first psychedelic-assisted treatments in 50 years.

ATAI

4 minute read

Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, ‘Synthetic Surprise,’ UK’s Harm Reduction Hub And More

By Lara Goldstein

January 26, 1:33 PM

Discover the latest research on psychedelics, from anti-inflammatory effects to end-of-life therapy. New journal issue and online course available.

AWKNF